FDA authorized first OTC at-home test to detect both influenza and COVID-19 viruses

, ,

On Feb. 24, 2023, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) at-home diagnostic test that can differentiate and detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19. The Lucira COVID-19 & Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes.

Tags:


Source: U.S. Food and Drug Administration
Credit: